Allogeneic Hemopoietic Stem Cell Transplants for Patients With Relapsed Acute Leukemia: Long-Term Outcome

Bone Marrow Transplantation - United Kingdom
doi 10.1038/sj.bmt.1705594
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Favorable Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory Acute Promyelocytic Leukemia in Childhood

Bone Marrow Transplantation
TransplantationHematology
2004English

CAR-T Cells and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Immunotherapy
OncologyAllergyImmunology
2017English

Outcomes in Patients With Relapsed or Refractory Acute Promyelocytic Leukemia Treated With or Without Autologous or Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2013English

Disease Progression Is Main Barrier to Allogeneic Hematopoietic Stem Cell Transplantation (HCT) in Patients With Newly Diagnosed and Relapsed Acute Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Outcome After Intensive Reinduction Therapy and Allogeneic Stem Cell Transplant in Paediatric Relapsed Acute Myeloid Leukaemia

British Journal of Haematology
Hematology
2017English

Nilotinib Restores Long-Term Full-Donor Chimerism in Ph-Positive Acute Lymphoblastic Leukemia Relapsed After Allogeneic Transplantation

Bone Marrow Transplantation
TransplantationHematology
2009English

Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation

Leukemia Research
Cancer ResearchOncologyHematology
2016English

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Acute Myeloid Leukemia Over 70 Years of Age: On Behalf of the Acute Leukemia Working Party of the EBMT

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Pcn126 - Direct Cost Study of Allogeneic Hematopoietic Stem Cell Transplantation (Ahsct) for Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Patients From the French Hospital Perspective

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy